Formula: | C20H25N3O2 |
Molecular Weight: | 339.44 |
Rotatable Bond Donors: | 4 |
clogP: | 3.59 |
Topological Polar Surface Area: | 54.46 |
Lipinski's RO5: | MW: 339.44 HBA: 5 HBD: 1 RB: 4 LogP: 3.59 |
Rule of Three: | MW: 339.44 HBA: 5 HBD: 1 RB: 4 LogP: 3.59 |
|
ECBD ID | Similarity | Structure | SDF |
---|
ECBD ID | Similarity | Structure | SDF | |
---|---|---|---|---|
EOS31919 | 0.74 | EOS31919 RDKit 3D 27 29 0 0 0 0 0 0 0 0999 V2000 -4.0008 1.6082 -4.4303 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.0394 1.1743 -3.0798 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.7383 1.3625 -2.5467 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.7243 0.9457 -1.0953 C 0 0 2 0 0 0 0 0 0 0 0 0 -1.3014 0.9959 -0.5730 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8442 -0.3724 -0.5890 N 0 0 0 0 0 0 0 0 0 0 0 0 0.4357 -0.7875 -0.2896 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7212 -1.9818 -0.2292 O 0 0 0 0 0 0 0 0 0 0 0 0 1.3177 0.2615 -0.0895 N 0 0 0 0 0 0 0 0 0 0 0 0 2.6777 0.1629 0.2258 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3367 -1.0522 0.3801 C 0 0 0 0 0 0 0 0 0 0 0 0 4.6931 -1.0742 0.6931 C 0 0 0 0 0 0 0 0 0 0 0 0 5.4061 0.1163 0.8558 C 0 0 0 0 0 0 0 0 0 0 0 0 6.7422 0.1470 1.1631 O 0 0 0 0 0 0 0 0 0 0 0 0 7.2815 -1.1624 1.2968 C 0 0 0 0 0 0 0 0 0 0 0 0 4.7442 1.3428 0.7021 C 0 0 0 0 0 0 0 0 0 0 0 0 5.4782 2.4891 0.8694 O 0 0 0 0 0 0 0 0 0 0 0 0 4.6818 3.6555 0.7050 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3825 1.3538 0.3873 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.9234 -1.3228 -0.6998 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.1793 -0.4994 -0.9345 C 0 0 1 0 0 0 0 0 0 0 0 0 -4.1411 -0.6479 0.2025 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.3473 -1.2915 -0.0403 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.2425 -1.4303 1.0137 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.9212 -0.9320 2.2691 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.6964 -0.3045 2.4165 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.7992 -0.1486 1.4163 N 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 4 3 1 6 4 5 1 0 5 6 1 0 6 7 1 0 7 8 2 0 7 9 1 0 9 10 1 0 10 11 2 0 11 12 1 0 12 13 2 0 13 14 1 0 14 15 1 0 13 16 1 0 16 17 1 0 17 18 1 0 16 19 2 0 6 20 1 0 20 21 1 0 21 22 1 1 22 23 2 0 23 24 1 0 24 25 2 0 25 26 1 0 26 27 2 0 21 4 1 0 27 22 1 0 19 10 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
GPR35 antagonism | primary assay | G-protein coupled receptor 35 | inactive |